Cargando…
Pulmonary aspergillosis and mucormycosis in a patient with COVID-19
Invasive pulmonary mucormycosis and aspergillosis are rare, life-threatening fungal infections. Most documented cases have been reported in patients with diabetes mellitus, neutropenia, or treatment with corticosteroids. Both infections have been recognized as secondary complications of COVID-19, es...
Autores principales: | Johnson, Andre K., Ghazarian, Zeron, Cendrowski, Kristina D., Persichino, Jon G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8025540/ https://www.ncbi.nlm.nih.gov/pubmed/33842203 http://dx.doi.org/10.1016/j.mmcr.2021.03.006 |
Ejemplares similares
-
Invasive pulmonary mucormycosis and aspergillosis in a patient with decompensated hepatic cirrhosis
por: Persichino, Jon G., et al.
Publicado: (2018) -
Dexamethasone: Pulmonary aspergillosis and mucormycosis: case report
Publicado: (2021) -
Dexamethasone: Pulmonary mucormycosis, pulmonary aspergillosis and off-label use: case report
Publicado: (2021) -
Tumor shape pulmonary mucormycosis associated with sinonasal aspergillosis in a diabetic patient
por: Point, Sophie, et al.
Publicado: (2017) -
Oral Mucormycosis and Aspergillosis in the Patient with Acute Leukemia
por: Vučićević Boras, Vanja, et al.
Publicado: (2019)